Physician profile
Marjorie E Field
NPI 1083732614
$1,761.53
in general payments reported to CMS, 2019-2025
18 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $294 · 2023: $390 · 2024: $456 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.70 | 2021-2025 | |
| Lilly USA, LLC | $310.93 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $292.25 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $181.80 | 2023-2025 | |
| Amgen INC. | $169.91 | 2021-2024 | Evenity, Prolia, Repatha |
| Novartis Pharmaceuticals Corporation | $95.96 | 2022-2023 | |
| Dexcom, INC. | $77.52 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $62.34 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $37.45 | 2024-2025 | Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $34.08 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $23.18 | 2024 | Veozah |
| Axsome Therapeutics, INC. | $20.34 | 2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $19.28 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.65 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $16.51 | 2025 | Uptravi, Opsumit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $16.45 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Hikma Pharmaceuticals USA | $15.96 | 2023 | Ryaltris, Mitigare |
| Kowa Pharmaceuticals America, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.